Patents Assigned to Johnson & Johnson Consumer France SAS
  • Patent number: 8636992
    Abstract: This invention relates to chemical compositions comprising two thickening components, which are sclerotium gum and a copolymer selected from the group consisting of methyl vinyl ether/maleic anhydride copolymer and acryloyldimethyltaurate vinylpyrrolidone copolymer, in particular the ammonium salt of the latter; which components provide good thickening properties in the presence of electrolytes, in particular in the presence of ethanolamine or vitamin salts. Further there are provided cosmetic formulations comprising these thickening components.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: January 28, 2014
    Assignee: Johnson & Johnson Consumer France SAS
    Inventors: Muriel Morelli, Agnes Le Fur, Carole Dupressoir
  • Patent number: 7928142
    Abstract: The present invention relates to a composition including at least one retinoid and at least one beta-aminoisobutyric acid derivative and the use thereof for the preparation of an article to be used for the topical application to skin, hair or nails.
    Type: Grant
    Filed: March 4, 2008
    Date of Patent: April 19, 2011
    Assignee: Johnson & Johnson Consumer France SAS
    Inventors: Thierry Oddos, Otto Von Stetten
  • Patent number: 7387807
    Abstract: This invention relates to a method of treating and preventing inflammatory disorders and related conditions using an extract of feverfew. Particularly, the invention includes a method of treating and preventing inflammatory disorders and related conditions which comprises applying a topical composition comprising an effective amount of an extract of feverfew to a patient and a method of treating and preventing inflammatory disorders and related conditions of the skin by applying a topical composition containing an effective amount of an extract of feverfew to a patient. In addition, the invention includes a method of treating and preventing inflammatory disorders and related conditions by applying a topical composition containing an effective amount of an extract of feverfew to a patient where said extract is substantially free of ?-unsaturated ?-lactone.
    Type: Grant
    Filed: June 16, 2005
    Date of Patent: June 17, 2008
    Assignee: Johnson & Johnson Consumer France, SAS, Roc Division
    Inventors: Theresa Callaghan, Thierry Oddos, Gerard Gendimenico, Katharine Martin
  • Patent number: 7262217
    Abstract: This invention relates to formulations containing a combination of anisic acid, or a salt thereof, or an ester thereof, and a C6-14 fatty acid monoglyceride and to the use of such combinations as a preservative system.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: August 28, 2007
    Assignee: Johnson & Johnson Consumer France SAS
    Inventors: Florence Baranger, Jean Francois Porracchia
  • Patent number: 7229650
    Abstract: This invention relates to a method of treating and preventing inflammatory disorders and related conditions using an extract of feverfew. Particularly, the invention includes a method of treating and preventing inflammatory disorders and related conditions which comprises applying a topical composition comprising an effective amount of an extract of feverfew to a patient and a method of treating and preventing inflammatory disorders and related conditions of the skin by applying a topical composition containing an effective amount of an extract of feverfew to a patient. In addition, the invention includes a method of treating and preventing inflammatory disorders and related conditions by applying a topical composition containing an effective amount of an extract of feverfew to a patient where said extract is substantially free of ?-unsaturated ?-lactone.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: June 12, 2007
    Assignee: Johnson & Johnson Consumer France SAS
    Inventors: Theresa Callaghan, Thierry Oddos, Gerard Gendimenico, Katharine Martin
  • Patent number: 6410062
    Abstract: This invention relates to a method of treating and preventing inflammatory disorders and related conditions using an extract of feverfew. Particularly, the invention includes a method of treating and preventing inflammatory disorders and related conditions which comprises applying a topical composition comprising an effective amount of an extract of feverfew to a patient and a method of treating and preventing inflammatory disorders and related conditions of the skin by applying a topical composition containing an effective amount of an extract of feverfew to a patient. In addition, the invention includes a method of treating and preventing inflammatory disorders and related conditions by applying a topical composition containing an effective amount of an extract of feverfew to a patient where said extract is substantially free of &agr;-unsaturated &ggr;-lactone.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: June 25, 2002
    Assignee: Johnson & Johnson Consumer France SAS I3540
    Inventors: Theresa Callaghan, Thierry Oddos, Gerard Gendimenico, Katharine Martin
  • Patent number: 6352698
    Abstract: The present invention relates to the use of at least two compounds chosen from components having an a) anti-radical, b) anti-inflammatory and c) anti-allergic activity for the preparation of a composition exhibiting at least two of the a), b) and c) activities intended for the treatment of sensitive and/or allergic skin. It also relates to a process for the preparation of such compositions and to the compositions thus obtained.
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: March 5, 2002
    Assignee: Johnson & Johnson Consumer France, SAS, ROC Division
    Inventors: Dominique Castelli, Gerd Ries, Laurence Friteau, Elisabeth Bousigniere, Laurent Fredon